-- title: "Porcine Reproductive and Respiratory Syndrome (PRRS) Virus: Genomic Surveillance and Control" category: "livestock-viruses" metaDescription: "A comprehensive review of PRRSV genomic surveillance, ORF5 sequencing, phylogenetic analysis, and control strategies including modified-live and killed vaccines." primaryKeyword: "PRRSV genomic surveillance" secondaryKeywords: ["ORF5 sequencing", "PRRSV phylogenetic analysis", "PRRSV modified-live vaccine", "PRRSV killed vaccine", "PRRSV control strategies"]
Porcine Reproductive and Respiratory Syndrome (PRRS) Virus: Genomic Surveillance and Control
Introduction
Porcine reproductive and respiratory syndrome virus (PRRSV) remains one of the most economically significant pathogens affecting the global swine industry [1, 5]. Since its emergence in the late 1980s, PRRSV has caused substantial losses through reproductive failure in breeding herds and respiratory disease in growing pigs [15]. The virus is characterized by high genetic diversity, rapid mutation rates, and complex immune evasion mechanisms that complicate control efforts [2, 12]. This article provides a comprehensive examination of PRRSV genomic surveillance methodologies, with particular emphasis on ORF5 sequencing and phylogenetic analysis, and evaluates current control strategies including modified-live virus (MLV) and killed virus vaccines.
Virology and Genomic Organization
PRRSV is an enveloped, positive-sense single-stranded RNA virus belonging to the family Arteriviridae, order Nidovirales [5]. The viral genome is approximately 15 kb in length and contains at least 10 open reading frames (ORFs). ORF1a and ORF1b encode the replicase polyproteins, which are processed into nonstructural proteins (nsps) involved in viral replication and pathogenesis [11]. ORF2a, ORF2b, ORF3, ORF4, ORF5, ORF6, and ORF7 encode structural proteins: GP2, E, GP3, GP4, GP5, M, and N, respectively [4, 10].
Two distinct species are recognized: Betaarterivirus suid 1 (PRRSV-1, formerly European genotype) and Betaarterivirus suid 2 (PRRSV-2, formerly North American genotype) [14, 22]. These species share approximately 60% nucleotide identity and exhibit significant antigenic differences [17]. Within each species, extensive genetic diversity exists, driven by high mutation rates, recombination, and selective pressure from host immunity and vaccination [2, 11].
Genomic Surveillance: ORF5 Sequencing and Phylogenetic Analysis
The Role of ORF5 in Surveillance
ORF5, encoding the major envelope glycoprotein GP5, is the most commonly targeted region for PRRSV molecular epidemiology [10, 17]. GP5 is the primary target for neutralizing antibodies and contains critical immunodominant epitopes [7, 10]. The high variability of ORF5, particularly within the ectodomain and N-glycosylation sites, makes it an ideal marker for tracking viral evolution and strain diversity [24].
ORF5-based phylogenetic analysis enables classification of PRRSV isolates into lineages and sublineages. For PRRSV-2, at least nine lineages have been described globally, with lineages 1 (NADC30-like), 3 (QYYZ-like), 5 (VR2332-like), and 8 (CH-1a-like and HP-PRRSV) being predominant in China [2, 17]. PRRSV-1 isolates are classified into subtypes I through IV, with subtype I being most prevalent in Europe and China [14, 22].
Sequencing Methodologies
Sanger sequencing of ORF5 amplicons remains the standard approach for routine genotyping [13]. However, the increasing availability of high-throughput sequencing platforms has enabled whole-genome sequencing and metagenomic approaches that provide higher resolution for recombination detection and evolutionary analysis [19, 30]. Targeted next-generation sequencing panels for swine respiratory pathogens, including PRRSV, have been developed and validated for simultaneous detection and genotyping [30].
Recombination Detection
Recombination is a major driver of PRRSV genetic diversity [2, 16, 21]. Multiple recombination events have been documented between different lineages and species, often involving vaccine-derived strains and field isolates [18, 22]. Recombination breakpoints are frequently identified in the nsp2 region and the structural protein coding regions, particularly ORF2-ORF5 [11, 22]. The emergence of novel recombinant strains, such as NADC34-like recombinants with enhanced pathogenicity, underscores the importance of continuous genomic surveillance [16, 21].
Phylogenetic Analysis Workflow
The following Mermaid diagram illustrates a typical workflow for PRRSV genomic surveillance and phylogenetic analysis:
flowchart TD
A[Clinical Sample Collection], > B[RNA Extraction]
B, > C[RT-PCR Amplification of ORF5]
C, > D[Sanger or High-Throughput Sequencing]
D, > E[Sequence Assembly and Quality Control]
E, > F[Multiple Sequence Alignment]
F, > G[Phylogenetic Tree Construction]
G, > H[Lineage and Sublineage Assignment]
H, > I[Recombination Analysis]
I, > J[Interpretation and Reporting]
J, > K[Integration with Epidemiological Data]
K, > L[Informed Control Strategy Decisions]
Diagnostic Assays for PRRSV
Molecular Detection Methods
Reverse transcription quantitative PCR (RT-qPCR) is the primary method for PRRSV detection due to its high sensitivity and specificity [13]. Multiplex RT-qPCR assays have been developed to differentiate PRRSV-1 and PRRSV-2, and to identify highly pathogenic lineages [23]. Locked nucleic acid (LNA) based probes enhance specificity for discriminating closely related variants [23].
Digital PCR (dPCR) provides absolute quantification without reliance on standard curves and is increasingly used for viral load determination in research settings [13]. Loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA) offer field-deployable alternatives for rapid screening [13].
Serological Methods
Enzyme-linked immunosorbent assays (ELISAs) targeting the N protein are widely used for herd-level serological monitoring [4, 13]. Indirect immunofluorescence assays (IFA) and immunoperoxidase monolayer assays (IPMA) provide confirmatory testing but are less suitable for high-throughput applications [13]. Virus neutralization tests remain the gold standard for detecting neutralizing antibodies, though they are labor-intensive and require cell culture facilities [5].
Antigen Detection
Immunohistochemistry (IHC) and immunofluorescence assays (IFA) on tissue sections allow visualization of viral antigen in situ, providing valuable information for pathogenesis studies [6, 15]. These methods are particularly useful for confirming PRRSV involvement in reproductive and respiratory lesions.
Control Strategies
Modified-Live Virus Vaccines
MLV vaccines are the most widely used intervention for PRRSV control [5, 18]. These vaccines are derived from attenuated field strains and provide partial protection against homologous and some heterologous challenges. However, MLVs have several limitations:
- Reversion to virulence: MLV strains can revert to pathogenic phenotypes through mutation or recombination with field strains [2, 18].
- Limited cross-protection: The high genetic diversity of PRRSV results in incomplete protection against heterologous strains, particularly those from different lineages [18].
- Recombination risk: MLV strains have been implicated in recombination events with field viruses, generating novel variants with unpredictable pathogenicity [2, 21].
- Interference with surveillance: Vaccinated animals cannot be serologically distinguished from infected animals using conventional ELISAs, complicating monitoring efforts [20].
Killed Virus Vaccines
Killed virus (KV) or inactivated vaccines are considered safer than MLVs as they cannot replicate or revert to virulence [5]. However, KV vaccines generally induce weaker cellular and humoral immune responses and provide inferior protection compared to MLVs [5]. Adjuvant formulation and antigen dose optimization are critical for improving KV vaccine efficacy.
Next-Generation Vaccine Approaches
Several novel vaccine strategies are under investigation:
- Subunit vaccines: Recombinant GP5 and other structural proteins expressed in various systems have been evaluated for immunogenicity [7, 10]. Multivalent approaches targeting multiple epitopes may improve cross-protection [7].
- DNA vaccines: Plasmid DNA encoding PRRSV antigens can induce both humoral and cellular immunity, though immunogenicity in pigs has been modest [5].
- Viral vector vaccines: Recombinant adenoviruses, pseudorabies viruses, and other vectors expressing PRRSV antigens have shown promise in experimental settings [5].
- Gene-edited pigs: CRISPR-Cas mediated modification of the CD163 gene, which encodes a key receptor for PRRSV entry, has produced pigs resistant to PRRSV infection [3]. This approach represents a paradigm shift in disease control, though regulatory and public acceptance barriers remain.
Herd Management and Biosecurity
Effective PRRSV control requires integration of vaccination with rigorous biosecurity measures [14, 20]. Key components include:
- Herd classification systems: Standardized protocols for classifying PRRSV status (positive unstable, positive stable, negative) facilitate communication and management decisions [20].
- Acclimation protocols: Controlled exposure of replacement gilts to farm-specific PRRSV strains can stabilize herd immunity [20].
- Air filtration: Reducing airborne transmission through filtration of incoming air in high-value breeding herds [20].
- All-in/all-out management: Segregated production and proper sanitation between groups reduce within-herd transmission.
Immune Evasion Mechanisms
PRRSV employs multiple strategies to evade host immune responses, contributing to persistent infection and vaccine failure [12]:
- Interference with interferon signaling: Nonstructural proteins, including nsp1, nsp2, and nsp11, inhibit type I interferon production and signaling [12, 28].
- Autophagy manipulation: PRRSV hijacks host autophagy pathways to enhance replication and degrade antiviral factors. For example, the E protein mediates degradation of DDX10 via SQSTM1/p62-dependent selective autophagy to antagonize innate immunity [9]. NSP2 also modulates lipophagy to promote viral replication [27].
- Antibody-dependent enhancement: Suboptimal neutralizing antibody responses may enhance viral entry into macrophages via Fc receptor mediated uptake [5].
- Glycan shielding: N-glycosylation of GP5 masks neutralizing epitopes, reducing antibody accessibility [10, 24].
- Apoptosis modulation: PRRSV can delay apoptosis in infected cells to prolong viral replication while inducing apoptosis in bystander immune cells [12].
Pathogenesis and Host Interactions
PRRSV exhibits a restricted cell tropism, primarily infecting porcine alveolar macrophages (PAMs) and other cells of the monocyte/macrophage lineage [5, 15]. Viral entry is mediated by interaction of GP5 and M heterodimers with CD163 and other receptors [3, 5].
Infection leads to profound immune dysregulation, characterized by:
- Cytokine storm: Highly pathogenic strains induce excessive proinflammatory cytokine production, including IL-1β and TNF-α, which disrupt pulmonary microvascular endothelial barriers through dysregulation of claudin-8 and claudin-4 [6].
- Lymphocyte depletion: PRRSV infection causes apoptosis of bystander lymphocytes, contributing to immunosuppression and increased susceptibility to secondary pathogens [5, 15].
- Persistent infection: Virus can persist in lymphoid tissues for weeks to months, with nsp2 genetic variation modulating persistence and virulence [11].
Emerging Strains and Global Epidemiology
PRRSV-2 Diversity
In China, four major PRRSV-2 lineages circulate: lineage 1 (NADC30-like), lineage 3 (QYYZ-like), lineage 5 (VR2332-like), and lineage 8 (CH-1a-like and HP-PRRSV) [2, 17]. NADC30-like strains, first detected in China in 2013, have become predominant and frequently recombine with other lineages, generating variants with enhanced pathogenicity [18]. NADC34-like strains, introduced more recently, have also undergone recombination with local strains [16, 21].
PRRSV-1 Emergence
PRRSV-1 has been increasingly detected in China since 2006, with at least seven independent subgroups identified based on ORF5 and whole-genome analysis [14, 22]. Some PRRSV-1 strains have acquired deletions in nsp2 and structural protein regions, and their pathogenicity appears to be increasing [14, 19]. The lack of licensed PRRSV-1 vaccines in China complicates control efforts [14].
Recombination Hotspots
High-frequency recombination regions are concentrated in nsp2 and the GP2-GP4 coding regions [22]. The nsp2 region is particularly prone to deletions, insertions, and substitutions that modulate virulence and immune recognition [11, 19].
Future Directions
Genomic surveillance of PRRSV must continue to evolve to address the challenges posed by high genetic diversity and recombination. Key priorities include:
- Standardized genotyping schemes: Harmonized lineage classification systems facilitate global comparisons and vaccine matching [17, 20].
- Real-time surveillance platforms: Integration of sequencing data with epidemiological and clinical information enables early detection of emerging variants [30].
- Computational modeling: Machine learning algorithms can predict viral evolution, recombination breakpoints, and antigenic relationships from genomic data [7].
- Broadly protective vaccines: Development of vaccines targeting conserved epitopes or incorporating multiple antigens may overcome the limitations of current MLVs [7].
- Gene editing for disease resistance: CRISPR-Cas mediated modification of CD163 has demonstrated proof-of-concept for PRRSV resistance in commercial pig populations [3].
Conclusion
PRRSV remains a formidable challenge to the global swine industry due to its genetic plasticity, immune evasion capabilities, and the limitations of current vaccines. Genomic surveillance, particularly through ORF5 sequencing and phylogenetic analysis, is essential for tracking viral diversity, detecting emerging recombinants, and informing control strategies. While MLV vaccines provide partial protection, their limitations necessitate continued development of next-generation vaccines and alternative control approaches, including gene editing for disease resistance. Integration of molecular diagnostics, bioinformatics, and herd management practices is critical for effective PRRSV control.
References
[1] Rajkhowa T. Porcine Reproductive and Respiratory Syndrome Virus. Emerging and Transboundary Animal Viruses. 2020. URL: https://www.semanticscholar.org/paper/b2dd7b37f80a7750d1c26f176be2d722c54612a3
[2] Zhou L, Han J, Yang H. The evolution and diversity of porcine reproductive and respiratory syndrome virus in China. Veterinary Microbiology. 2024. URL: https://www.semanticscholar.org/paper/c991a817e126db523b3126256d17c1253a1e34cf
[3] Burger BT, Beaton B, Campbell MA, et al. Generation of a Commercial-Scale Founder Population of Porcine Reproductive and Respiratory Syndrome Virus Resistant Pigs Using CRISPR-Cas. The CRISPR Journal. 2024. URL: https://www.semanticscholar.org/paper/ada3549c3a57edfd74a3421a3bfe3795c4129103
[4] Zheng Y, Li G, Luo Q, et al. Research progress on the N protein of porcine reproductive and respiratory syndrome virus. Frontiers in Microbiology. 2024. URL: https://www.semanticscholar.org/paper/1874dcbf556fb51fca4ad5214a3410627f3159d1
[5] Fiers J, Cay A, Maes D, et al. A Comprehensive Review on Porcine Reproductive and Respiratory Syndrome Virus with Emphasis on Immunity. Vaccines. 2024. URL: https://www.semanticscholar.org/paper/20777c9ae462a4d41d3a9e8063f26ab381b6d31f
[6] Sun W, Wu W, Fang X, et al. Disruption of pulmonary microvascular endothelial barrier by dysregulated claudin-8 and claudin-4: uncovered mechanisms in porcine reproductive and respiratory syndrome virus infection. Cellular and Molecular Life Sciences. 2024. URL: https://www.semanticscholar.org/paper/ba411bbc8cabb82114d3879cbed1ac692db10753
[7] Dey S, Bruner J, Brown MH, et al. Identification and biophysical characterization of epitope atlas of Porcine Reproductive and Respiratory Syndrome Virus. Computational and Structural Biotechnology Journal. 2024. URL: https://www.semanticscholar.org/paper/4e91845369a7ab895076b914c1396cb8a52ea79d
[8] Chen X, Yu Z, Li W. Molecular mechanism of autophagy in porcine reproductive and respiratory syndrome virus infection. Frontiers in Cellular and Infection Microbiology. 2024. URL: https://www.semanticscholar.org/paper/b14a88823f623c80677df538acffe3954212a944
[9] Li J, Zhou Y, Zhao W, et al. Porcine reproductive and respiratory syndrome virus degrades DDX10 via SQSTM1/p62-dependent selective autophagy to antagonize its antiviral activity. Autophagy. 2023. URL: https://www.semanticscholar.org/paper/5732c843c55d11e73e083564fe9b024f1e8986a9
[10] Luo Q, Zheng Y, Zhang H, et al. Research Progress on Glycoprotein 5 of Porcine Reproductive and Respiratory Syndrome Virus. Animals. 2023. URL: https://www.semanticscholar.org/paper/d7f4d2c1ab96dee80edf8a75f6649fe919165bb2
[11] Kong C, Li D, Hu Y, et al. The Genetic Variation of Porcine Reproductive and Respiratory Syndrome Virus Replicase Protein nsp2 Modulates Viral Virulence and Persistence. Journal of Virology. 2023. URL: https://www.semanticscholar.org/paper/355cc33f7d5244cf0da810b9db94affe273547ce
[12] Chen X, Qiao S, Li R, et al. Evasion strategies of porcine reproductive and respiratory syndrome virus. Frontiers in Microbiology. 2023. URL: https://www.semanticscholar.org/paper/08804572b04ae782eaba344d23144989a6e9997f
[13] Pan J, Zeng M, Zhao M, et al. Research Progress on the detection methods of porcine reproductive and respiratory syndrome virus. Frontiers in Microbiology. 2023. URL: https://www.semanticscholar.org/paper/ee7ce7767b63a7ca5f1a8c18a870f9b453853bce
[14] Sun Q, Xu H, An T, et al. Recent Progress in Studies of Porcine Reproductive and Respiratory Syndrome Virus 1 in China. Viruses. 2023. URL: https://www.semanticscholar.org/paper/cc4260a80fd9be22867d002b10b78d6b4e5f94ba
[15] Lunney J, Fang Y, Ladinig A, et al. Porcine Reproductive and Respiratory Syndrome Virus (PRRSV): Pathogenesis and Interaction with the Immune System. Annual Review of Animal Biosciences. 2016. URL: https://www.semanticscholar.org/paper/bb0265e959ace24251423806323b59b8f2b56ec9
[16] Zhou L, Yu J, Zhou J, et al. A novel NADC34-like porcine reproductive and respiratory syndrome virus 2 with complex genome recombination is highly pathogenic to piglets. Infection, Genetics and Evolution. 2023. URL: https://www.semanticscholar.org/paper/c01c4d19a30c75fad9eba0671d9f619072c76ee5
[17] Guo Z, Chen X, Li R, et al. The prevalent status and genetic diversity of porcine reproductive and respiratory syndrome virus in China: a molecular epidemiological perspective. Virology Journal. 2018. URL: https://www.semanticscholar.org/paper/a3059e27557864612330681acfa4ae6968fee925
[18] Yu Y, Zhang Q, Cao Z, et al. Recent Advances in Porcine Reproductive and Respiratory Syndrome Virus NADC30-Like Research in China: Molecular Characterization, Pathogenicity, and Control. Frontiers in Microbiology. 2022. URL: https://www.semanticscholar.org/paper/cc8d9f295c145549259ce2b4e495f01cc093c528
[19] Li C, Qiu M, Li S, et al. Metagenomic and Pathogenic Assessments Identify a Pathogenic Porcine Reproductive and Respiratory Syndrome Virus 1 with New Deletions from Adult Slaughter Pig in 2022. Transboundary and Emerging Diseases. 2023. URL: https://www.semanticscholar.org/paper/faaf9905b4f206e7401c053fa7cfa948e44e8988
[20] Holtkamp D, Torremorell M, Corzo C, et al. Proposed modifications to porcine reproductive and respiratory syndrome virus herd classification. Journal of Swine Health and Production. 2021. URL: https://www.semanticscholar.org/paper/d779ded391892dac9e95c5dacc5ccd165f5011d8
[21] Sun Y, Liu Y, Yang J, et al. Recombination between NADC34-like and QYYZ-like strain of Porcine Reproductive and Respiratory Syndrome virus with high pathogenicity for piglets in China. Transboundary and Emerging Diseases. 2022. URL: https://www.semanticscholar.org/paper/888fcb427981bd2e570508923db4c51982981a76
[22] Yu F, Liu L, Tian X, et al. Genomic Analysis of Porcine Reproductive and Respiratory Syndrome Virus 1 Revealed Extensive Recombination and Potential Introduction Events in China. Veterinary Sciences. 2022. URL: https://www.semanticscholar.org/paper/232540b418ad082a2f86e7affa55266ca27e5524
[23] Gyurján I, Sipos-Kozma Z, Ásványi B, et al. Development and validation of an LNA-based one-step multiplex RT-qPCR assay for differentiating Betaarterivirus europensis (PRRSV-1), Betaarterivirus americense (PRRSV-2), and the highly pathogenic L8 lineage of PRRSV-2. Veterinary Journal. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42235629/
[24] Cotaquispe Nalvarte RY, Legua Barrios M, De la Cruz Vásquez E, et al. Genetic variability, N-glycosylation, and recombination in sublineage 1A of Betaarterivirus americense from commercial pig farms in Lima, 2019. Frontiers in Microbiology. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42232907/
[25] Bischoff H, Beumer M, Helmer C, et al. Retrospective analysis of infectious agents in swine abortion materials in the years 2021 to 2023. Veterinary Research Communications. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42213157/
[26] Tran HT, Mercado AJ, Lahoti MM, et al. Effects of a novel feed additive on clinical symptoms and the nasal and cecal microbiome in nursery pigs challenged with PRRSV and Streptococcus suis. Translational Animal Science. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42211862/
[27] Zhu Z, Lin Q, Zhang X, et al. PRRSV NSP2 hijacks host lipophagy via a LIPE-PNPLA2-AMPK-MTOR axis to promote viral replication. Autophagy. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42200529/
[28] Liu D, Yan Y, Fu X, et al. Porcine Reproductive and Respiratory Syndrome Virus NSP8 Suppresses NF-κB Signaling by Hijacking Host UBE2K and IKKα. Viruses. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42198770/
[29] Melini CM, Kikuti M, Yue X, et al. An Exploratory Pilot Study to Investigate the Potential Relationship Between Porcine Reproductive and Respiratory Syndrome (PRRS) Virus Viremia Changes and Barn Manure Pit Management Procedures. Pathogens. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42198580/
[30] Elshafie NO, Wilkes RP. Analytic and Diagnostic Validation of a Targeted Next-Generation Sequencing Panel for Common and Emerging Swine Respiratory Pathogens. Microorganisms. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42197544/